167262-42-2

Basic information

• Product Name: 3-(3,4-DICHLOROPHENYL)-1-(3,4,5-TRIMETHOXYBENZOYL)-3-PYRROLIDINEETHANOL METHANSULFONATE
• Synonyms: 3-(3,4-DICHLOROPHENYL)-1-(3,4,5-TRIMETHOXYBENZOYL)-3-PYRROLIDINEETHANOL METHANSULFONATE;3-(3,4-dichloro-phenyl-)-1-(3,4,5-trimethoxy--benz-oyl-)-3-pyrrol-idineethanol methansulfo-te
• CAS NO: 167262-42-2
• Molecular Formula: C₂₃H₂₇Cl₂NO₇S
• Molecular Weight: 532.43
• Mol File: 167262-42-2.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(3,4-DICHLOROPHENYL)-1-(3,4,5-TRIMETHOXYBENZOYL)-3-PYRROLIDINEETHANOL METHANSULFONATE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3,4-DICHLOROPHENYL)-1-(3,4,5-TRIMETHOXYBENZOYL)-3-PYRROLIDINEETHANOL METHANSULFONATE(167262-42-2)
• EPA Substance Registry System: 3-(3,4-DICHLOROPHENYL)-1-(3,4,5-TRIMETHOXYBENZOYL)-3-PYRROLIDINEETHANOL METHANSULFONATE(167262-42-2)

Safety Data

• Hazardous Substances Data: 167262-42-2(Hazardous Substances Data)

Upstream product

• 52423-89-9 3-(3,4-dichloro-phenyl)-3-(2-hydroxy-ethyl)-pyrrolidine 
• 178370-78-0 1-(3,4,5-trimethoxy-benzoyl)-3-(3,4-dichloro-phenyl)-3-(2-acetoxy-ethyl)-pyrrolidine 
• 167262-41-1 3-(3,4-dichloro-phenyl)-1-(3,4,5-trimethoxy-benzoyl)-3-(2-hydroxy-ethyl)-pyrrolidine 
• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 167261-47-4 MDL 103392 

Relevant articles and documents

SUBSTITUTED 4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPANES USEFUL FOR THE TREATMENT ALLERGIC DISEASES

The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4] diazepane derivatives of formula (1): and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.

Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease

The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4]diazepane derivatives of formula (1): and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.

Novel substituted 4-(1H-benzimidazol-2-yl) [1,4]diazepanes useful for the treatment of allergic diseases

The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4]diazepane derivatives of formula and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.